{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:07:18Z","timestamp":1791176838439,"version":"4.1.0"},"reference-count":36,"publisher":"The Endocrine Society","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"DOI":"10.1210\/en.2012-1481","type":"journal-article","created":{"date-parts":[[2012,11,3]],"date-time":"2012-11-03T05:00:39Z","timestamp":1351918839000},"page":"5896-5905","source":"Crossref","is-referenced-by-count":17,"title":["Contribution of Endogenous Glucocorticoids and Their Intravascular Metabolism by 11\u03b2-HSDs to Postangioplasty Neointimal Proliferation in Mice"],"prefix":"10.1210","volume":"153","author":[{"given":"Javaid","family":"Iqbal","sequence":"first","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsay J.","family":"Macdonald","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Low","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Seckl","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Yau","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Walker","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W. F.","family":"Hadoke","sequence":"additional","affiliation":[{"name":"University\/BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041122232720500_B1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1476-5381.2008.00047.x","article-title":"Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.","volume":"156","author":"Hadoke","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2019041122232720500_B2","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-07-0455","article-title":"Glucocorticoids and cardiovascular disease.","volume":"157","author":"Walker","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"2019041122232720500_B3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/13543784.17.4.481","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 (11\u03b2-HSD1) inhibitors in type 2 diabetes mellitus and obesity 3390.","volume":"17","author":"Hughes","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"2019041122232720500_B4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1210\/endo.142.4.8114","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1\u2014a tissue-specific amplifier of glucocorticoid action.","volume":"142","author":"Seckl","year":"2001","journal-title":"Endocrinology"},{"key":"2019041122232720500_B5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0083-6729(08)60646-9","article-title":"11\u03b2-Hydroxysteroid dehydrogenase.","volume":"57","author":"Stewart","year":"1999","journal-title":"Vitam Horm"},{"key":"2019041122232720500_B6","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1210\/endo-129-6-3305","article-title":"11\u03b2-Hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids.","volume":"129","author":"Walker","year":"1991","journal-title":"Endocrinology"},{"key":"2019041122232720500_B7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.HYP.0000088855.06598.5B","article-title":"Glucocorticoid action in mouse aorta; localisation of 11\u03b2-hydroxysteroid dehydrogenase type 2 and effects on response to glucocorticoid in vitro.","volume":"42","author":"Christy","year":"2003","journal-title":"Hypertension"},{"key":"2019041122232720500_B8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(96)88542-7","article-title":"Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, and aldosterone antagonist.","volume":"29","author":"Van Belle","year":"1995","journal-title":"Cardiovasc Res"},{"key":"2019041122232720500_B9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/hc3001.091458","article-title":"Eplerenone suppresses constrictive remodeling and collagen accumulation after angioplasty in porcine coronary arteries.","volume":"104","author":"Ward","year":"2001","journal-title":"Circulation"},{"key":"2019041122232720500_B10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijcard.2005.03.078","article-title":"Eplerenone suppresses neointimal formation after coronary stent implantation in swine.","volume":"107","author":"Wakabayashi","year":"2006","journal-title":"Int J Cardiol"},{"key":"2019041122232720500_B11","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1161\/hc4801.100077","article-title":"Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11\u03b2-hydroxysteroid dehydrogenase.","volume":"104","author":"Hadoke","year":"2001","journal-title":"Circulation"},{"key":"2019041122232720500_B12","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0500641102","article-title":"Preventing local regeneration of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase type 1 enhances angiogenesis.","volume":"102","author":"Small","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122232720500_B13","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.4049\/jimmunol.176.12.7605","article-title":"Local amplification of glucocorticoids by 11\u03b2-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes.","volume":"176","author":"Gilmour","year":"2006","journal-title":"J Immunol"},{"key":"2019041122232720500_B14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2011-1398","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice.","volume":"153","author":"Coutinho","year":"2012","journal-title":"Endocrinology"},{"key":"2019041122232720500_B15","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"2019041122232720500_B16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0021-9150(00)00605-5","article-title":"Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol-fed rabbits.","volume":"155","author":"Poon","year":"2001","journal-title":"Atherosclerosis"},{"key":"2019041122232720500_B17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.20050119","article-title":"11\u03b2-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.","volume":"202","author":"Hermanowski-Vosatka","year":"2005","journal-title":"J Exp Med"},{"key":"2019041122232720500_B18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1463-1326.2009.01034.x","article-title":"Antidiabetic effects of 11\u03b2-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.","volume":"11","author":"Lloyd","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"2019041122232720500_B19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI4445","article-title":"Hypertension in mice lacking 11\u03b2-hydroxysteroid dehydrogenase type 2.","volume":"103","author":"Kotelevtsev","year":"1999","journal-title":"J Clin Invest"},{"key":"2019041122232720500_B20","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress.","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122232720500_B21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1210\/en.2006-0996","article-title":"Intravascular glucocorticoid metabolism during inflammation and injury in mice.","volume":"148","author":"Dover","year":"2007","journal-title":"Endocrinology"},{"key":"2019041122232720500_B22","first-page":"111P","article-title":"Development and application of an automated direct radioimmunoassay for plasma aldosterone [proceedings].","volume":"81","author":"Al-Dujaili","year":"1979","journal-title":"J Endocrinol"},{"key":"2019041122232720500_B23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0039-128X(96)00252-8","article-title":"In vivo and in vitro effects of carbenoxolone on glucocorticoid receptor binding and glucocorticoid activity.","volume":"62","author":"Soro","year":"1997","journal-title":"Steroids"},{"key":"2019041122232720500_B24","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1161\/01.ATV.0000204635.75748.0f","article-title":"Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.","volume":"26","author":"Suzuki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041122232720500_B25","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11\u03b2-hydroxysteroid dehydrogenase type 1 null mice.","volume":"276","author":"Morton","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041122232720500_B26","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome.","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"2019041122232720500_B27","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: hepatic overexpression of 11\u03b2-hydroxysteroid dehydrogenase type 1 in transgenic mice.","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041122232720500_B28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11\u03b2-hydroxysteroid dehydrogenase type 1-deficient mice.","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"2019041122232720500_B29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1210\/en.2010-0925","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apo-E\u2212\/\u2212 mice.","volume":"152","author":"Deuchar","year":"2011","journal-title":"Endocrinology"},{"key":"2019041122232720500_B30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2007.03.043","article-title":"Pretreatment with eplerenone reduces stroke volume in mouse middle cerebral artery occlusion model.","volume":"566","author":"Iwanami","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"2019041122232720500_B31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/00005344-200306000-00019","article-title":"Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice.","volume":"41","author":"Keidar","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"key":"2019041122232720500_B32","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11\u03b2-Hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"2019041122232720500_B33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2011.01375.x","article-title":"Effects of an 11\u03b2-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.","volume":"13","author":"Feig","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"2019041122232720500_B34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jash.2011.01.009","article-title":"Efficacy and safety of the selective 11\u03b2-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension.","volume":"5","author":"Shah","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"2019041122232720500_B35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4049\/jimmunol.167.1.30","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages.","volume":"167","author":"Thieringer","year":"2001","journal-title":"J Immunol"},{"key":"2019041122232720500_B36","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.2337\/db10-0830","article-title":"Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11\u03b2-hydroxysteroid dehydrogenase type 1-deficient mice.","volume":"60","author":"Wamil","year":"2011","journal-title":"Diabetes"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/153\/12\/5896\/10385874\/endo5896.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T16:50:38Z","timestamp":1555087838000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/153\/12\/5896\/2424442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2012-1481","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}